Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03105154 · ClinicalTrials.gov registry record · NA
Groin Wound Infection Rate Using Prevena Compared to Standard Dressing in Vascular Surgery Patients With High Risk
A NA study of Endovascular Procedures, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT03105154: Completed NA study of Endovascular Procedures, sponsored by The Cleveland Clinic.
NCT03105154 is a NA study of Endovascular Procedures that has completed, run by The Cleveland Clinic. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03105154, a NA study of Endovascular Procedures, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate wound healing using Prevena compared to standard dressings in high risk patients after vascular surgery.
Primary Outcome
% of wound occurrence in the Prevena treated groin compared to conventional treated groin
Conditions Studied
Interventions
- OTHER Prevena Dressing
- OTHER Conventional Dressing
Study Locations (1)
Ohio
- Clevealnd Clnic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-02 |
| Est. Completion | 2020-11-10 |
| Phase | NA |
What the finished NCT03105154 record still lists
NCT03105154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Endovascular Procedures appearing as the primary indexed condition, and to 2 interventions - of which Prevena Dressing is the first listed.
NCT03105154 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03105154 about?
NCT03105154 is a clinical study titled "Groin Wound Infection Rate Using Prevena Compared to Standard Dressing in Vascular Surgery Patients With High Risk". Evaluate wound healing using Prevena compared to standard dressings in high risk patients after vascular surgery.
What is the current status of trial NCT03105154?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-02. Estimated completion is 2020-11-10.
What conditions does trial NCT03105154 study?
This clinical trial studies the following conditions: Endovascular Procedures.
What interventions are being tested in trial NCT03105154?
The interventions under investigation include: Prevena Dressing (OTHER), Conventional Dressing (OTHER).
Who is sponsoring clinical trial NCT03105154?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03105154 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03105154's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia